Literature DB >> 2198023

The effects of amylin on carbohydrate metabolism in skeletal muscle in vitro and in vivo.

B Leighton1, E Foot.   

Abstract

1. The effects of synthetic human amylin on basal and insulin-stimulated (100 and 1000 microunits/ml) rates of lactate formation, glucose oxidation and glycogen synthesis were measured in the isolated rat soleus muscle preparation incubated in the presence of various concentrations of glucose (5, 11 and 22 mM). 2. The rate of glucose utilization was increased by about 2-fold by increasing the glucose concentration from 5 to 22 mM. 3. Synthetic human amylin (10 nM) significantly inhibited (by 46-56%) glycogen synthesis, irrespective of the concentration of insulin or glucose present in the incubation medium. 4. Amylin (10 nM) did not affect insulin-stimulated rates of 2-deoxy[3H]glucose transport and phosphorylation. 5. Intraperitoneal administration of insulin (100 micrograms/kg) to rats in vivo stimulated the rate of [U-14C]glucose incorporation into glycogen in the diaphragm by about 80-fold. This rate was decreased (by 28%) by co-administration of amylin (66 micrograms/kg).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2198023      PMCID: PMC1131524          DOI: 10.1042/bj2690019

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide.

Authors:  J M Molina; G J Cooper; B Leighton; J M Olefsky
Journal:  Diabetes       Date:  1990-02       Impact factor: 9.461

2.  Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration.

Authors:  M Nakazato; J Asai; K Kangawa; S Matsukura; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

3.  Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.

Authors:  B Leighton; G J Cooper
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

4.  Localization of calcitonin gene-related peptide and its receptors in a striated muscle.

Authors:  P Popper; P E Micevych
Journal:  Brain Res       Date:  1989-09-04       Impact factor: 3.252

5.  Suppression of insulin-stimulated glucose transport in L6 myocytes by calcitonin gene-related peptide.

Authors:  D Kreutter; S J Orena; K M Andrews
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

6.  Muscle glycogen synthesis and disposition of infused glucose in humans with reduced rates of insulin-mediated carbohydrate storage.

Authors:  A A Young; C Bogardus; D Wolfe-Lopez; D M Mott
Journal:  Diabetes       Date:  1988-03       Impact factor: 9.461

7.  Glucose-induced insulin resistance of skeletal-muscle glucose transport and uptake.

Authors:  E A Richter; B F Hansen; S A Hansen
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

Review 8.  Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus.

Authors:  G J Cooper; A J Day; A C Willis; A N Roberts; K B Reid; B Leighton
Journal:  Biochim Biophys Acta       Date:  1989-12-14

9.  Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus.

Authors:  A N Roberts; B Leighton; J A Todd; D Cockburn; P N Schofield; R Sutton; S Holt; Y Boyd; A J Day; E A Foot
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Secretion of islet amyloid polypeptide in response to glucose.

Authors:  A Kanatsuka; H Makino; H Ohsawa; Y Tokuyama; T Yamaguchi; S Yoshida; M Adachi
Journal:  FEBS Lett       Date:  1989-12-18       Impact factor: 4.124

View more
  9 in total

Review 1.  Islet amyloid polypeptide--a novel controversy in diabetes research.

Authors:  P Westermark; K H Johnson; T D O'Brien; C Betsholtz
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

Review 2.  Amylin, amyloid and age-related disease.

Authors:  G J Cooper; C A Tse
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

3.  Physiological glucocorticoid levels regulate glutamine and insulin-mediated glucose metabolism in skeletal muscle of the rat. Studies with RU 486 (mifepristone).

Authors:  B Leighton; M Parry-Billings; G Dimitriadis; J Bond; E A Newsholme; C DaCosta; E A Foot
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

4.  Acute effects of phorbol esters on the protein-synthetic rate and carbohydrate metabolism of normal and mdx mouse muscles.

Authors:  P A MacLennan; A McArdle; R H Edwards
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

5.  Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol ester-stimulated glucose transport in in vitro incubated human muscle strips.

Authors:  J R Zierath; D Galuska; A Engström; K H Johnson; C Betsholtz; P Westermark; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

6.  Amylin impairment of insulin effects on glycogen synthesis and phosphoenolpyruvate carboxykinase gene expression in rat primary cultured hepatocytes.

Authors:  S Baqué; J J Guinovart; A M Gómez-Foix
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

7.  Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits.

Authors:  G T Westermark; L Christmanson; G Terenghi; J Permerth; C Betsholtz; J Larsson; J M Polak; P Westermark
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

8.  The role of the sensory peptide calcitonin-gene-related peptide(s) in skeletal muscle carbohydrate metabolism: effects of capsaicin and resiniferatoxin.

Authors:  B Leighton; E A Foot
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

Review 9.  Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases.

Authors:  Nina Sonne; Morten A Karsdal; Kim Henriksen
Journal:  Mol Metab       Date:  2020-11-07       Impact factor: 7.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.